Notes to SEFA
Title: Basis of Presentation
Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting.Such expenditures are recognized following the cost principles contained in the UniformGuidance for all awards. Under these principles, certain types of expenditures are notallowable or are limited as to reimbursement. Any negative amounts shown on the Schedulerepresent adjustments or credits made in the normal course of business to amountsreported as expenditures in prior years.During the year ended December 31, 2022, Ashe Memorial Hospital did not makesubrecipient payments with the federal funds listed in the schedule of expenditures offederal awards.
De Minimis Rate Used: N
Rate Explanation: The auditee did not use the de minimis cost rate.
The accompanying schedule of expenditures of federal awards (the Schedule) includes thefederal award activity of Ashe Memorial Hospital and Affiliates under programs of the federalgovernment for the year ended December 31, 2022. The information in this Schedule ispresented in accordance with the requirements of 2 CFR Part 200, Uniform AdministrativeRequirements, Cost Principles, and Audit Requirements for Federal Awards (UniformGuidance). Because the Schedule presents only a selected portion of the operations ofAshe Memorial Hospital, it is not intended to and does not present the net assets, changesin net assets, or cash flows of Ashe Memorial Hospital.The consolidated financial statements reflect revenue recognized from the Provider ReliefFund of approximately $3,099,000 and $2,153,000 for the years ended December 31, 2022and 2021. The Schedule includes Provider Relief Funds of approximately $1,683,000 thatwere received in Period 4 in accordance with the requirements of the compliancesupplement for assistance listing number 93.498. The consolidated financial statementsreflect revenue recognized that consists of 50% of the Provider Relief Funds that werereceived in Period 1 and 50% of the Provider Relief Funds that were received in Period 4.